Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,800
Closed -$4.44M 1836
2026
Q1
$4.44M Buy
58,800
+25,000
+74% +$1.88M 0.03% 564
2025
Q4
$2.52M Buy
+33,800
New +$2.47M 0.02% 759
2025
Q2
Sell
-45,000
Closed -$2.78M 1657
2025
Q1
$2.78M Hold
45,000
0.03% 583
2024
Q4
$3.24M Buy
+45,000
New +$3.52M 0.03% 528
2022
Q4
Sell
-18,000
Closed -$1.16M 1463
2022
Q3
$1.16M Sell
18,000
-57,000
-76% -$3.95M 0.02% 814
2022
Q2
$5.2M Hold
75,000
0.07% 343
2022
Q1
$5.76M Buy
75,000
+60,000
+400% +$4.31M 0.07% 372
2021
Q4
$1.15M Buy
+15,000
New +$1.1M 0.01% 995
2020
Q3
Sell
-50,000
Closed -$2.85M 1131
2020
Q2
$2.85M Buy
+50,000
New +$2.45M 0.09% 295
2020
Q1
Sell
-50,000
Closed -$2.61M 947
2019
Q4
$2.61M Buy
+50,000
New +$2.49M 0.09% 308

Other funds holding HOLX

Caption Management's HOLX Position: Q2 2026 in Review

Caption Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 53,137 shares — an estimated $4.02M sold.

Caption Management first reported a position in HOLX in Q4 2019 and held it in 8 quarters. The position peaked at $6.74M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Caption Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 53,137 Hologic shares in Q2 2026, an estimated $4.02M.
  • Caption Management first reported a position in Hologic in Q4 2019 and held it in 8 quarters.
  • Caption Management's Hologic position peaked at $6.74M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.